90
Participants
Start Date
September 12, 2025
Primary Completion Date
March 31, 2028
Study Completion Date
May 31, 2028
CD70-targeted CAR-T cells
Administration method: intravenous infusion. Subjects will receive conditioning therapy by Fludarabine and Cyclophosphamide before cell infusion.
CD70-targeted CAR-T cells
Administration method: intrapleural infusion. Subjects will receive conditioning therapy by Fludarabine and Cyclophosphamide before cell infusion.
CD70-targeted CAR-T cells
Administration method: intraperitoneal infusion. Subjects will receive conditioning therapy by Fludarabine and Cyclophosphamide before cell infusion.
RECRUITING
The 901 Hospital of Joint Logistics Support Force of People Liberation Army, Hefei
Chongqing Precision Biotech Co., Ltd
INDUSTRY